US 10906916
Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
granted A61KA61K31/519A61P
Quick answer
US patent 10906916 (Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors) held by Valo Early Discovery, Inc. expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Valo Early Discovery, Inc.
- Grant date
- Tue Feb 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/519, A61P, A61P25/00, A61P29/02